The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I) n n n n n n n n n n which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.